Live Breaking News & Updates on Autoimmune Thyroid Disease

Stay updated with breaking news from Autoimmune thyroid disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Catalyst Pharmaceuticals Receives Two New U.S. Patent

New Patents Further Reinforce the FIRDAPSE® (amifampridine) Intellectual Patent Portfolio. ....

United States , Patrickj Mcenany , Steven Miller , Catalyst Pharmaceuticals Inc , Catalyst Or Company Nasdaq , Exchange Commission , Trademark Office , Catalyst Pharmaceuticals , Health Canada , United States Patent , Chief Executive Officer , Chief Operating Officer , Chief Scientific Officer , North America , Duchenne Muscular , Fast Track , Full Prescribing , Safety Information , Full Prescribing Information , Annual Report , Nasdaq Cprx , Catalyst Pharmaceuticals , Muscular Dystrophy , Myasthenia Gravis , Rare Disease , Lambert Eaton ,

Women in Science: Kathryn Starzyk on the power and complexities of RWE

Kathryn Starzyk is an epidemiologist nad currently vice president of real-world evidence (RWE) at healthcare technology company, OM1. ....

National Institute Of Child Health , Human Development , National Institute , Child Health , Bio Developments , Markets Amp Regulations , Emerging Markets , Women In Science , Real World Evidence ,

Scinai Reports Third Quarter 2023 Financial Results and

JERUSALEM, Oct. 31, 2023 (GLOBE NEWSWIRE) via IBN Scinai Immunotherapeutics Ltd (Nasdaq: SCNI), a biopharmaceutical company focused on developing,. ....

Israel General , United States , Joshua Phillipson , Los Angeles , Scinai Immunotherapeutics , Max Planck , Company Annual Report On Form , Corporate Communications , Exchange Commission , Pipeline Development , Company Contact , Scinai Immunotherapeutics Ltd Nasdaq , Company Adss , European Investment Bank , University Medical Center , Exchange Commission On , Hc Wainwright Co , Scinai Immunotherapeutics Ltd , Private Litigation Reform Act , Nasdaq Listing , Nasdaq Listing Rules , Annual Report , Nasdaq Scni , Scinai Immunotherapeutics Ltd , Scinai Immunotherapeutics Ltd , Nasdaq Scni ,

Immune-Mediated Inflammatory Diseases Increase Despite Available Treatment

Results highlighted a growing number of incident cases of asthma, inflammatory bowel disease, multiple sclerosis, psoriasis, atopic dermatitis, and rheumatoid arthritis from 1990 to 2019. ....

United States , Lai Shan Tam , Department Of Medicine , National Multiple Sclerosis Society , Chinese University Of Hong Kong , Global Health Data Exchange , Chinese University , Hong Kong , Global Burden , North America , Saharan Africa , Clin Cell , Multiple Sclerosis , Rheumatoid Arthritis ,

Patients With RA Are at Increased Risk for Aortic Stenosis, Study Suggests

Results from a retrospective, matched cohort study suggested that valvular heart disease and aortic stenosis may contribute to disparities in cardiovascular disease–related mortality in patients with rheumatoid arthritis (RA). ....

Veterans Health Administration , Disease Concept , Rheumatic Disease Comorbidity Index , Rheumatoid Arthritis , Cardiovascular Disease , Valvular Heart Disease , Aortic Stenosis ,